Skip to main content
UniHealth

Doctor search

Tanya Ghosh, MD

Ophthalmology · Los Altos

NPI 1417045600

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
2 carriers
Offices
2

Offices

2 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group

Looking this up.

Plans that list them

14 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Ghosh’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence G65383 · Current

Licensed to practise in California · since 1989 · expires 2028-06-30 · Virginia Commonwealth University, Medical College of Virginia.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Original Medicare doctor bills

$997,538

Medicare paid this office $997,538 for 567 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg75$359,212None
Injection, aflibercept hd, 1 mg22$188,718None
Injection, faricimab-svoa, 0.1 mg23$137,890None
Injection of drug into eye180$102,184$124
Return visit (30+ min)427$50,767$113
See all 15 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg75$359,212None
Injection, aflibercept hd, 1 mg22$188,718None
Injection, faricimab-svoa, 0.1 mg23$137,890None
Injection of drug into eye180$102,184$124
Return visit (30+ min)427$50,767$113
Imaging of retina415$42,823$39
Compounded drug, not otherwise classified106$37,778None
New patient visit (45+ min)91$12,595$138
Photography of the retina190$7,071$35
Short return visit (20+ min)61$6,322$83
Removal of recurring cataract in lens capsule using a laser17$6,231$328
Exam of retinal blood vessels using a special camera after injection of a dye19$3,517$176
Short return visit28$1,573$44
Injection, bevacizumab, 10 mg11$627None
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's21$315$15

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

567 Original Medicare patients in 2024. Average age 79 · Under 65 2% · 85 and older 27% · Women 57% · Also on Medicaid 16% · Health risk score 1.23. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 70% · Diabetes 36% · Chronic kidney disease 29% · Coronary heart disease 28% · Atrial fibrillation 17% · Cancer 14% · Heart failure 13% · Depression 13% · COPD 9% · Stroke 6% · Dementia 5%.

The office billed $3,407,039, Medicare allowed $1,277,814 and paid $997,538; for 11,502 services of 31 kinds; $701,923 of it was for drugs given in the office and $295,615 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202456711,502791.23$3,407,039$997,538
202353810,849791.21$2,945,473$920,621
20225376,239791.28$2,886,065$1,030,511
20215114,733791.21$2,642,554$988,699
20204444,838791.47$2,630,820$997,374
20195165,268781.41$2,795,552$1,032,422
20185284,454791.43$2,317,184$850,185
20174994,477781.49$1,785,573$643,323
20164694,439771.32$1,633,782$558,751
20154424,478771.47$1,566,419$497,015
20144442,663771.30$1,338,998$445,168
20134342,621751.37$1,316,007$427,916

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg81$527,377None
Injection of drug into eye187$109,713$125
Injection, faricimab-svoa, 0.1 mg30$83,775None
Return visit (30+ min)380$46,296$111
Imaging of retina374$44,017$40
Compounded drug, not otherwise classified116$38,798None
New patient visit (45+ min)121$16,587$137
Short return visit (20+ min)72$6,867$80
Photography of the retina151$5,773$37
Exam of retinal blood vessels using a special camera after injection of a dye21$3,090$147
Short return visit21$1,648$52

2022: 12 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg81$718,085None
Injection of drug into eye195$114,528$122
Imaging of retina380$45,320$40
Compounded drug, not otherwise classified127$44,316None
Return visit (30+ min)355$41,835$112
New patient visit (45+ min)111$15,905$143
Removal of recurring cataract in lens capsule using a laser18$6,786$339
Short return visit (20+ min)63$6,726$79
Injection, faricimab-svoa, 0.1 mg14$5,372None
Long return visit (40+ min)35$4,613$132
Exam of retinal blood vessels using a special camera after injection of a dye11$1,479$134
Photography of the retina32$1,252$36

2021: 14 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg62$657,781None
Injection of drug into eye197$123,845$125
Compounded drug, not otherwise classified138$52,919None
Imaging of retina350$46,739$41
Return visit (30+ min)335$40,145$111
New patient visit (45+ min)94$13,207$141
Long return visit (40+ min)40$6,897$172
Removal of recurring cataract in lens capsule using a laser16$5,361$335
Short return visit (20+ min)46$4,969$87
Exam of retinal blood vessels using a special camera after injection of a dye27$3,389$126
Photography of the retina45$1,685$37
Short return visit24$1,302$45
New patient visit (30+ min)11$1,057$96
Injection, bevacizumab, 10 mg11$753None

2020: 10 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg63$680,794None
Injection of drug into eye193$101,878$108
Compounded drug, not otherwise classified125$45,852None
Imaging of retina322$41,767$40
Return visit (30+ min)330$34,021$93
New patient visit (45+ min)64$7,847$123
Removal of recurring cataract in lens capsule using a laser12$4,416$340
Exam of retinal blood vessels using a special camera after injection of a dye28$3,093$110
Short return visit (20+ min)27$1,903$59
Photography of the retina38$1,637$41

2019: 11 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg60$684,872None
Injection of drug into eye187$106,463$107
Imaging of retina359$46,165$39
Return visit (30+ min)371$37,244$93
Compounded drug, not otherwise classified121$27,401None
New patient visit (45+ min)80$10,895$136
Injection, bevacizumab, 10 mg90$10,834None
Short return visit (20+ min)80$6,775$63
Exam of retinal blood vessels using a special camera after injection of a dye40$3,739$93
Photography of the retina58$2,769$48
New patient visit (30+ min)15$1,412$94

2018: 12 services

Original Medicare services billed in 2018
Injection, aflibercept, 1 mg47$511,027None
Injection of drug into eye162$92,242$103
Imaging of retina362$43,675$39
Return visit (30+ min)363$36,396$90
Compounded drug, not otherwise classified124$28,641None
New patient visit (45+ min)104$14,103$136
Short return visit (20+ min)76$6,729$67
Removal of recurring cataract in lens capsule using a laser12$3,915$326
Photography of the retina62$3,603$54
Exam of retinal blood vessels using a special camera after injection of a dye40$3,476$85
New patient visit (30+ min)15$1,220$81
Short return visit24$980$36

2017: 13 services

Original Medicare services billed in 2017
Injection, aflibercept, 1 mg43$353,990None
Injection of drug into eye151$74,265$101
Imaging of retina320$35,825$38
Return visit (30+ min)323$32,160$92
Compounded drug, not otherwise classified106$19,215None
New patient visit (45+ min)122$16,294$134
Injection, bevacizumab, 10 mg26$7,616None
Photography of the retina65$4,329$66
Short return visit (20+ min)53$4,055$60
Removal of recurring cataract in lens capsule using a laser11$3,361$306
Exam of retinal blood vessels using a special camera after injection of a dye40$3,075$77
New patient visit (30+ min)19$1,796$95
Short return visit24$1,027$32

2016: 12 services

Original Medicare services billed in 2016
Injection, aflibercept, 1 mg39$293,230None
Injection of drug into eye142$66,914$102
Return visit (30+ min)317$31,532$91
Imaging of retina232$31,339$43
Compounded drug, not otherwise classified117$19,360None
New patient visit (45+ min)90$12,859$143
Exam of retinal blood vessels using a special camera after injection of a dye50$7,262$104
Photography of the retina87$6,457$73
Short return visit (20+ min)73$5,745$62
New patient visit (30+ min)18$1,208$67
Short return visit20$1,040$39
Exam of visual field with extended testing12$771$64

2015: 12 services

Original Medicare services billed in 2015
Injection, aflibercept, 1 mg31$231,323None
Injection of drug into eye140$59,820$104
Imaging of retina247$30,774$45
Return visit (30+ min)264$26,739$97
Unclassified biologics103$14,505None
New patient visit (45+ min)66$10,050$152
Exam of retinal blood vessels using a special camera after injection of a dye46$8,574$110
Photography of the retina89$7,326$79
Short return visit (20+ min)76$6,377$64
New patient visit (30+ min)31$2,913$94
Short return visit14$793$42
Exam of visual field with extended testing11$743$62

2014: 15 services

Original Medicare services billed in 2014
Injection, aflibercept, 1 mg24$175,793None
Injection, ranibizumab, 0.1 mg11$114,717None
Injection of drug into eye105$44,658$95
Imaging of retina236$25,716$43
Return visit (30+ min)241$22,902$93
Unclassified biologics79$12,988None
Short return visit (20+ min)90$6,928$59
New patient visit (45+ min)49$6,716$137
Exam of retinal blood vessels using a special camera after injection of a dye34$5,844$103
Photography of the retina65$4,932$75
Established patient complete exam of visual system43$3,760$87
New patient visit (30+ min)26$2,578$99
Established patient problem focused exam of visual system20$1,645$75
New patient complete exam of visual system11$1,344$122
Exam of visual field with extended testing11$578$53

2013: 19 services

Original Medicare services billed in 2013
Injection, aflibercept, 1 mg25$187,792None
Injection of drug into eye105$39,246$83
Imaging of retina194$21,779$44
Established patient complete exam of visual system124$13,009$105
Unclassified biologics87$12,997None
Return visit (30+ min)122$11,733$93
New patient complete exam of visual system78$9,673$124
Exam of retinal blood vessels using a special camera after injection of a dye44$8,111$107
Short return visit (20+ min)83$7,299$62
Destruction of growth of retina using a laser12$6,496$464
Photography of the retina79$5,758$69
New patient visit (45+ min)31$4,555$147
Destruction of vascular growth between retina and sclera by photodynamic therapy14$4,505$250
Established patient problem focused exam of visual system32$3,018$75
Examination of eye by ophthalmoscope with retinal drawing33$1,163$26
Imaging of optic nerve28$1,108$38
Exam of visual field with extended testing15$967$60
Injection, verteporfin, 0.1 mg14$123None
Injection, dexamethasone sodium phosphate, 1 mg14$2None

Medicaid work

$20,150 in 2024

Medicaid paid $20,150 for 352 billed services this clinician did in 2024, up to 23 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Intravitreal injection of a pharmacologic agent (separate procedure)168$17,918
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina184$2,232
Medicaid work by year
2024352223$20,150
2023500332$19,032
2022244224$11,852
2021382223$12,813
2020238320$11,846
201941215$1,975
201842316$3,381
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Intravitreal injection of a pharmacologic agent (separate procedure)211$16,107
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina264$2,493
Return visit (30+ min)25$432

2022

Largest Medicaid services in 2022
Intravitreal injection of a pharmacologic agent (separate procedure)131$10,955
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina113$897

2021

Largest Medicaid services in 2021
Intravitreal injection of a pharmacologic agent (separate procedure)185$11,311
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina197$1,502

2020

Largest Medicaid services in 2020
Intravitreal injection of a pharmacologic agent (separate procedure)106$10,138
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina120$1,516
Return visit (30+ min)12$193

2019

Largest Medicaid services in 2019
Intravitreal injection of a pharmacologic agent (separate procedure)14$1,283
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina27$692

2018

Largest Medicaid services in 2018
Intravitreal injection of a pharmacologic agent (separate procedure)13$2,048
Return visit (30+ min)16$929
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina13$404

Drugs they prescribed that Part D paid

$10,966

Pharmacies billed $10,966 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 78) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

50 generic and 28 brand-name prescriptions · $10,966 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Erythromycin12$188$16
Latanoprost15$152$10
Dorzolamide-Timolol14$114$8

Year by year

Part D prescribing by year
202478370% (0)36%$10,966
202363240% (0)37%$7,076
202289350% (0)24%$11,425
202194390% (0)34%$12,500
202088250% (0)33%$12,491
201912634None42%$12,018
201833673None22%$14,452
2017162440% (0)35%$10,471
2016304825% (15)29%$22,218
201521061None34%$17,735
201482240% (0)55%$8,288
201311841None56%$8,958

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Dorzolamide-Timolol15$553$37
Prednisolone Acetate13$542$42
Erythromycin16$185$12

2022: 3 drugs

Part D drugs prescribed in 2022
Dorzolamide-Timolol18$688$38
Latanoprost14$599$43
Erythromycin12$147$12

2021: 1 drug

Part D drugs prescribed in 2021
Erythromycin17$212$12

2020: 2 drugs

Part D drugs prescribed in 2020
Olopatadine13$592$46
Erythromycin11$125$11

2019: 4 drugs

Part D drugs prescribed in 2019
Eliquis26$5,795$223
Latanoprost13$353$27
Atorvastatin12$132$11
Carvedilol12$85$7

2018: 5 drugs

Part D drugs prescribed in 2018
Latanoprost41$931$23
Ipratropium-Albuterol11$452$41
Erythromycin23$210$9
Brimonidine18$178$10
Furosemide11$65$6

2017: 3 drugs

Part D drugs prescribed in 2017
Prednisolone Acetate11$510$46
Naproxen12$230$19
Brimonidine13$147$11

2016: 8 drugs

Part D drugs prescribed in 2016
Humalog Mix 75-25 Kwikpen18$5,390$299
Latanoprost24$391$16
Brimonidine12$345$29
Metoprolol18$286$16
Simvastatin12$257$21
Timolol Maleate11$146$13
Furosemide11$62$6
Warfarin11$55$5

2015: 4 drugs

Part D drugs prescribed in 2015
Dorzolamide-Timolol11$355$32
Latanoprost27$332$12
Timolol Maleate23$240$10
Erythromycin18$215$12

2014: 4 drugs

Part D drugs prescribed in 2014
Restasis14$4,016$287
Dorzolamide-Timolol11$544$49
Latanoprost21$278$13
Timolol Maleate14$112$8

2013: 4 drugs

Part D drugs prescribed in 2013
Patanol13$1,747$134
Latanoprost29$591$20
Dorzolamide-Timolol11$583$53
Acyclovir11$185$17

Money from drug and device companies

$70 in 2025

Industry payments by year
202522None$70
202422$150$245
202311None$294
202211None$124
202011None$19
201946None$653

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Harrow EyeIheezo$41
1 payment
  • Meals for Iheezo · 2025-05-14 · $41
ANI PharmaceuticalsIluvien$29
1 payment
  • Meals for Iluvien · 2025-09-05 · $29
See all 2 published payments
Every published payment
ANI PharmaceuticalsMeals · 2025-09-05Iluvien$29
Harrow EyeMeals · 2025-05-14Iheezo$41
See earlier years (2024, 2023, 2022, 2020, 2019)

2024: $245

Payments by company in 2024
Cardinal Health 110None$150
1 payment
  • Consulting · 2024-02-02 · $150
Regeneron Healthcare SolutionsEylea Hd$95
1 payment
  • Meals for Eylea Hd · 2024-10-18 · $95

2023: $294

Payments by company in 2023
Carl Zeiss Meditec USACirrus 5000 With Angioplex$294
1 payment
  • Long term medical supply or device loan for Cirrus 5000 With Angioplex · 2023-06-30 · $294

2022: $124

Payments by company in 2022
Apellis PharmaceuticalsNone$124
1 payment
  • Meals · 2022-09-21 · $124

2020: $19

Payments by company in 2020
Carl Zeiss Meditec AGNone Specified$19
1 payment
  • Gift for None Specified · 2020-04-26 · $19

2019: $653

Payments by company in 2019
Novartis PharmaceuticalsNone$299
3 payments
  • Meals · 2019-10-29 · $124
  • Meals · 2019-06-13 · $72
  • Meals · 2019-05-16 · $102
AbbVieHumira$125
1 payment
  • Meals for Humira · 2019-08-26 · $125
Genentech USALucentis$123
1 payment
  • Meals for Lucentis · 2019-03-12 · $123
Hoffmann-La RocheNon-Covered Product$107
1 payment
  • Meals for Non-Covered Product · 2019-03-21 · $107

Professional record

NPI
1417045600
Licence
CA G65383California G65383: Current · expires 2028-06-30
Trained
Virginia Commonwealth University, School of Medicine, 1987
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
2350 W El Camino Real, 2nd Floor, Mountain View, CA, 94040
NPI first listed
2006-10-11
NPI last updated
2011-12-01

This is when the NPI record was last certified, not a medical board exam.